Mark Glenn

1.1k total citations
25 papers, 916 citations indexed

About

Mark Glenn is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Mark Glenn has authored 25 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Mark Glenn's work include Viral gastroenteritis research and epidemiology (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). Mark Glenn is often cited by papers focused on Viral gastroenteritis research and epidemiology (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). Mark Glenn collaborates with scholars based in United Kingdom, United States and Germany. Mark Glenn's co-authors include Thomas F. Schulz, Lucille Rainbow, Andrew J. Davison, Alan Radford, Philip Turner, Frédéric Aurade, Susan Dawson, F. McArdle, Rosalind M. Gaskell and Mirko Zuzel and has published in prestigious journals such as Nature Communications, Blood and Cancer Research.

In The Last Decade

Mark Glenn

23 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Glenn United Kingdom 16 360 290 268 169 165 25 916
Patrick Gonin France 22 174 0.5× 355 1.2× 81 0.3× 218 1.3× 349 2.1× 52 1.1k
Gloria Ramírez Colombia 14 365 1.0× 306 1.1× 576 2.1× 94 0.6× 293 1.8× 58 1.3k
Ramin S. Herati United States 23 189 0.5× 392 1.4× 286 1.1× 57 0.3× 335 2.0× 35 1.6k
Miriam Lieberman United States 16 213 0.6× 321 1.1× 227 0.8× 116 0.7× 459 2.8× 34 1.4k
Dorina Ujvári Sweden 14 148 0.4× 172 0.6× 517 1.9× 322 1.9× 103 0.6× 32 892
Nicole A. P. Lieberman United States 16 142 0.4× 316 1.1× 169 0.6× 35 0.2× 264 1.6× 33 903
Margaret K. Offermann United States 21 643 1.8× 377 1.3× 527 2.0× 37 0.2× 318 1.9× 34 1.4k
Donatella Negri Italy 24 236 0.7× 496 1.7× 293 1.1× 54 0.3× 464 2.8× 68 1.5k
John G. Howe United States 15 798 2.2× 274 0.9× 367 1.4× 16 0.1× 250 1.5× 36 1.3k
James Skare United States 21 437 1.2× 147 0.5× 340 1.3× 18 0.1× 567 3.4× 41 1.3k

Countries citing papers authored by Mark Glenn

Since Specialization
Citations

This map shows the geographic impact of Mark Glenn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Glenn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Glenn more than expected).

Fields of papers citing papers by Mark Glenn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Glenn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Glenn. The network helps show where Mark Glenn may publish in the future.

Co-authorship network of co-authors of Mark Glenn

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Glenn. A scholar is included among the top collaborators of Mark Glenn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Glenn. Mark Glenn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soul, Jamie, Aditi Kanhere, Mark Glenn, et al.. (2025). Deletion of 17p in cancers: Guilt by (p53) association. Oncogene. 44(10). 637–651. 1 indexed citations
2.
Glenn, Mark, et al.. (2024). Expression of versican isoforms V0/V1 by pancreatic cancer associated fibroblasts increases fibroblast proliferation. Pancreatology. 24(5). 719–731. 2 indexed citations
3.
Ireland, Lucy, Mark Glenn, Christopher Halloran, et al.. (2024). Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. Cancer Research. 84(4). 527–544. 19 indexed citations
4.
Raymant, Meirion, Yuliana Astuti, Daniel M. Green, et al.. (2024). Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer. Nature Communications. 15(1). 3593–3593. 37 indexed citations
5.
Clifford, R, Paul Sutton, Matthew Fok, et al.. (2024). Myoferlin: A Potential Marker of Response to Radiation Therapy and Survival in Locally Advanced Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(4). 1111–1123.
6.
Austin, James, Rosalind E. Jenkins, Mark Glenn, et al.. (2019). Cancerous inhibitor of protein phosphatase 2A (CIP2A) modifies energy metabolism via 5′ AMP-activated protein kinase signalling in malignant cells. Biochemical Journal. 476(15). 2255–2269. 3 indexed citations
7.
Glenn, Mark, Benjamin Brown, Piera Angelillo, et al.. (2017). Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CβII in chronic lymphocytic leukaemia cells. Scientific Reports. 7(1). 43228–43228. 5 indexed citations
8.
Vartak, Supriya V., Archita Mishra, Gunaseelan Goldsmith, et al.. (2016). Identification of a novel BCL2‐specific inhibitor that binds predominantly to the BH1 domain. FEBS Journal. 283(18). 3408–3437. 32 indexed citations
9.
Glenn, Mark, et al.. (2014). Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy. Blood. 123(21). 3277–3285. 26 indexed citations
10.
Lin, Ke, Mark Glenn, Robert J. Harris, et al.. (2006). c-Abl Expression in Chronic Lymphocytic Leukemia Cells: Clinical and Therapeutic Implications. Cancer Research. 66(15). 7801–7809. 31 indexed citations
11.
Strauss, Gordon D., et al.. (2005). Psychiatric Disposition of Patients Brought in by Crisis Intervention Team Police Officers. Community Mental Health Journal. 41(2). 223–228. 60 indexed citations
12.
Kamiguti, Aura S., Kathleen J. Till, R. J. C. Harris, et al.. (2004). The role of matrix metalloproteinase  9 in the pathogenesis of chronic lymphocytic leukaemia. British Journal of Haematology. 125(2). 128–140. 74 indexed citations
13.
Brinkmann, Melanie M., Mark Glenn, Lucille Rainbow, et al.. (2003). Activation of Mitogen-Activated Protein Kinase and NF-κB Pathways by a Kaposi's Sarcoma-Associated Herpesvirus K15 Membrane Protein. Journal of Virology. 77(17). 9346–9358. 108 indexed citations
14.
Radford, Alan, Mark Glenn, Susan Dawson, et al.. (2002). DNA vaccination against feline calicivirus infection using a plasmid encoding the mature capsid protein. Vaccine. 20(13-14). 1787–1796. 11 indexed citations
15.
Pettitt, Andrew R., et al.. (2002). Response of hairy cells to IFN-α involves induction of apoptosis through autocrine TNF-α and protection by adhesion. Blood. 100(2). 647–653. 51 indexed citations
16.
Glenn, Mark, Alan Radford, Philip Turner, et al.. (1999). Nucleotide sequence of UK and Australian isolates of feline calicivirus (FCV) and phylogenetic analysis of FCVs. Veterinary Microbiology. 67(3). 175–193. 62 indexed citations
17.
Radford, Alan, Malcolm Bennett, F. McArdle, et al.. (1999). Quasispecies evolution of a hypervariable region of the feline calicivirus capsid gene in cell culture and persistently infected cats. Veterinary Microbiology. 69(1-2). 67–68. 16 indexed citations
18.
Bello, Leonard J., Andrew J. Davison, Mark Glenn, et al.. (1999). The human herpesvirus-8 ORF 57 gene and its properties. Journal of General Virology. 80(12). 3207–3215. 67 indexed citations
19.
Radford, Alan, Malcolm J. Bennett, F. McArdle, et al.. (1998). Quasispecies evolution of a hypervariable region of the feline calicivirus capsid gene in cell culture and in persistently infected cats.. Journal of General Virology. 79(1). 1–10. 77 indexed citations
20.
Radford, Alan, Malcolm Bennett, F. McArdle, et al.. (1997). The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures. Vaccine. 15(12-13). 1451–1458. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Gonin Breakdown of academic impact, for papers by Gloria Ramírez Breakdown of academic impact, for papers by Ramin S. Herati Breakdown of academic impact, for papers by Miriam Lieberman Breakdown of academic impact, for papers by Dorina Ujvári Breakdown of academic impact, for papers by Nicole A. P. Lieberman Breakdown of academic impact, for papers by Margaret K. Offermann Breakdown of academic impact, for papers by Donatella Negri Breakdown of academic impact, for papers by John G. Howe Breakdown of academic impact, for papers by James Skare
Rankless by CCL
2026